INFORMATION ABOUT THE PHARMACEUTICAL SECTOR IN POLAND

T.U. Federation of Chemical, Glass and Ceramic Industries in Poland.

Józef Woźny- President

National Pharmaceutical Industry plays an important role in the Polish health & care system provides patients with affordable medicines available to treat most illnesses.

It also has a great importance for the economy of providing 55% of the medicines sold in Poland.

Polish pharmaceutical industry is one of the largest generic medicines producer in Europe.

It provides public access to medicines of good quality with benefit price (more than 50% of the packages in the market comes from domestic plants).

Pharmaceutical Sector in Poland

Average prices of generic and innovative medicines in Europe(net producer prices, EUR)

Niemcy

Finlan

diaBelg

ia

Luks

embu

rg

Norweg

ia

Austri

a

Portu

galia

Grecja

Hiszpa

nia

Fran

cja

Słowac

ja

Włochy

Wlk. B

rytan

ia

Węgry

Esto

niaŁo

twa

Litwa

Rumun

ia

Polska

Bułgar

ia0

2

4

6

8

10

12

14

16

18 17.1

14.613.312.912.6

10.09.2 9.0

8.37.1 6.6 6.5 6.4 5.9 5.9

4.7 4.5 4.2 3.6 3.0

Structure of the Polish pharmaceutical market broken down by original and generic medicines in 2011 (net producer prices).

Quantitative Valuable

Oryginal Generic

Only one plant-Polfa Tarchomin remains in the hands of the Treasury.

Pharmaceutical Sector in Poland:

Privatization process:

Polfa Poznań GlaxoSmithKlinePolfa Rzeszów Valeant (formerly ICN)Polfa Kraków Pliva /TevaPolfa Grodzisk Gedeon RichterPolfa Kutno TevaFabryka w Starogardzie Gdańskim

National invetor- Jerzy Starak

Polfa Pabianice National company-Adamed

Domestic pharmaceutical companies more than 60% of the profit is investing. These investments have allowed companies such as for:

Process to complete implementation of Quality Management Systems, implementation of Good Manufacturing Practice (GMP),

the adjustment of medicines documents with European Union requirements,

employment restructuring, development cooperation programs in science, increase in the number of patents, the development of biotechnology, the adaptation of production to high standards of environmental protection.  Domestic pharmaceutical companies spend on research and development, 13% of the profits, where the average for the processing industry in Poland is 3.5%.

Pharmaceutical Sector in Poland

The export of medicines to EU countries are 75.6%. Among the countries to which exported the Polish medicine complex, the majority were:

Germany (15.5% of Polish exports) and the United Kingdom,

France and Russia (about 9% of Polish foreign sales).

Pharmaceutical Sector in Poland

Domestic pharmaceutical industry employs approx. 23 000 peoples.

Amount of workers in pharmaceutical industry in the years 2006-2010 (in the person of the end of the year)

Salary in the manufacturing industry was 3 250.00 PLN in the pharmaceutical industry 5 319.00 PLN.

The average monthly salary per employee in manufacturing and pharmaceutical industry

in the years 2006-2010.

Trade Union membership in the pharmaceutical industry is in the range of 30-35%.

In the factories functioning Works Collective Labour Agreements.

Where are the European Works Council representatives of Polish pharmaceutical companies are authorized.

Works Council functioning of each plant.

Multi-establishment collective agreement is not signed, has not given its consent Employers Association of Pharmaceutical Industries.

Pharmaceutical Sector in Poland

Activities in the area of corporate social responsibility

Charitable activities

Sponsoring of sport and cultural news

Organized of seminars and science conferences

Information actions for the patients

Investments in environmental

Free diagnostics for patients

Other

Companies don’t take activities on this field.

Impacts that could affect most business development in Polish pharmaceutical sector.

The introduction a new products in market

The overall increase in wealth of the society

The access to reimbursement

The access to investment funds

Improving the law system

The marketing actions

Improving quality of products

Output from outside the polish market

Increasing health consciousness of Poles

Increasing of amount of sales representatives

 

THANK YOU FOR ATTENTION !

Presentation prepared on the basis of the documentation:1. Polish Employers Association in the Pharmaceutical Industry 2. Department of Economic Information- Invest In Poland3. T.U. Federation of Chemical, Glass and Ceramic Industries in Poland

Pharmaceutical Sector in Poland